BSESampre Nutritions LtdMediumNeutral
Announced Fri, 13 Feb · 19:07 IST

Board meeting outcome for standalone and consolidated unaudited financial results for the third quarter and nine-month period ended 31 December 2025; with appointment of a non-executive ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sampre Nutritions' Board met on 13 February 2026 and approved two key items. First, the standalone and consolidated unaudited financial results for the third quarter and nine months ended 31 December 2025 were taken on record, with limited review reports issued by statutory auditors NGRAO & Associates. Second, Pradeep Narendra Poddar (DIN: 00025199) was appointed as a non-executive non-independent additional director with effect from 13 February 2026. Poddar holds an MBA and a Bachelor's in Chemical Engineering, and brings around four decades of experience in the food processing industry. He is not related to any existing directors on the board. His appointment is subject to shareholder approval under SEBI Listing Regulations. The meeting ran from 1:30 PM to 4:30 PM IST.

Likely market impact

Routine quarterly results approval combined with the addition of an industry-experienced board member; no immediate material impact on share price expected, though investors should watch for the detailed Q3 numbers in the published results and any updates on subsidiary performance in the consolidated figures.